Breaking News Instant updates and real-time market news.

AVP

Avon Products

$3.09

-0.11 (-3.44%)

15:44
05/13/19
05/13
15:44
05/13/19
15:44

Natura secures financing for potential Avon bid, Bloomberg says

Natura Cosmeticos has secured offers from Banco Santander, Itau Unibanco and Banco Bradesco to fund a potential deal to buy Avon Products, according to Bloomberg, citing people with knowledge of the matter. The three banks haven't made definitive commitments as the company has not finalized its acquisition plan, one source told Bloomberg.

  • 16

    May

AVP Avon Products
$3.09

-0.11 (-3.44%)

09/24/18
DADA
09/24/18
UPGRADE
Target $3.5
DADA
Buy
Avon Products upgraded to Buy at DA Davidson on operational focus of new CEO
As reported earlier, DA Davidson analyst Linda Bolton Weiser upgraded Avon Products (AVP) to Buy from Hold and raised her price target to $3.50 from $1.75. The analyst cites the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability". Based on her increased confidence in Avon's management team, Weiser also raised her target enterprise value to expected FY20 EBITDA target multiple to 6.5-times from 4.5-times, which is still a discount to other direct sellers like Nu Skin (NUS) and Herablife (HLF) trading at 11- to 12-times
09/24/18
09/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Plains All American (PAA) and Plains GP Holdings (PAGP) were upgraded to Buy from Hold at Stifel. 2. Avon Products (AVP) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability." 3. United Natural Foods (UNFI) upgraded to Sector Perform at RBC Capital with analyst William Kirk saying while core business challenges for the company remain and the risk of the Supervalu acquisition integration continues, its 6.4-times earnings valuation likely accounts for these issues. 4. KVH Industries (KVHI) upgraded to Buy from Neutral at Chardan with analyst James McIlree saying he expects "continued strong growth" from its Agile Plans that should result in improved margins and increased financial predictability. 5. RELX (RELX) upgraded to Overweight from Equal Weight at Barclays with analyst Nick Dempsey saying he views the current valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/25/19
DADA
03/25/19
NO CHANGE
Target $3.5
DADA
Buy
Avon Products buyout could be valued as high as $4.50/shr, says DA Davidson
DA Davidson analyst Linda Bolton Weiser kept her Buy rating and $3.50 price target on Avon Products after the latest speculation about its potential acquisition by Natura. The analyst believes that the takeout valuation could come at $3.80-$4.50 per share, but intends to assess the Brazil anti-trust rules while also noting Natura's already "leveraged balance sheet, with over $2B of debt and debt-to-EBITDA of 4.3-times".
05/10/19
SBSH
05/10/19
NO CHANGE
SBSH
Natura paying 50% premium for Avon 'not the base case,' says Citi
Citi analyst Tobias Stingelin noted that Spanish website Intereconomia.com reported, citing a source, that Santander's board has approved a loan of up to $2.1B for Natura, which he notes has already publicly announced that it is engaged in talks to buy Avon. An all cash transaction of $2.1B, or a 50% premium, is unlikely in his view and he does not believe that this is the base case, Stingelin tells investors. He believes that if a transaction were to take place for Avon it would be at a lower premium and noted that Intereconomia's source said a deal could still be for a combination of cash and stock. Stingelin has a Neutral rating on Natura shares. In afternoon trading, Avon shares are up nearly 10% to $3.18.

TODAY'S FREE FLY STORIES

TGT

Target

$103.11

17.54 (20.50%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Recommendations
Target analyst commentary  »

Target valuation remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Hot Stocks
Dick's Sporting CEO says 'we are very pleased with our second quarter results' »

"We are very pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HMSY

HMS Holdings

$38.69

-0.19 (-0.49%)

07:36
08/22/19
08/22
07:36
08/22/19
07:36
Downgrade
HMS Holdings rating change  »

HMS Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:35
08/22/19
08/22
07:35
08/22/19
07:35
Hot Stocks
Dick's Sporting sees FY19 CapEx approximately $230M on gross basis »

In 2019, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

CLSD

Clearside Biomedical

$1.27

0.09 (7.66%)

07:35
08/22/19
08/22
07:35
08/22/19
07:35
Hot Stocks
Breaking Hot Stocks news story on Clearside Biomedical »

Clearside Biomedical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:34
08/22/19
08/22
07:34
08/22/19
07:34
Hot Stocks
Dick's Sporting says continuing strategic review of hunt business »

The company is continuing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:33
08/22/19
08/22
07:33
08/22/19
07:33
Hot Stocks
Dick's Sporting sees FY19 SSS growth in 'low single-digits' »

Consolidated same store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:31
08/22/19
08/22
07:31
08/22/19
07:31
Earnings
Dick's Sporting raises FY19 EPS view to $3.30-$3.45 from $3.20-$3.40 

FY19 consensus $3.31.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

PSTG

Pure Storage

$13.87

0.2 (1.46%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Oct

  • 12

    Dec

  • 16

    Dec

DKS

Dick's Sporting

$32.97

0.62 (1.92%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Earnings
Dick's Sporting reports Q2 EPS $1.26, consensus $1.21 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

NBL

Noble Energy

$22.22

-0.02 (-0.09%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Upgrade
Noble Energy rating change  »

Noble Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 02

    Oct

TSLA

Tesla

$220.89

-4.81 (-2.13%)

, TGT

Target

$103.11

17.54 (20.50%)

07:30
08/22/19
08/22
07:30
08/22/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TSLA

Tesla

$220.89

-4.81 (-2.13%)

TGT

Target

$103.11

17.54 (20.50%)

BCS

Barclays

$6.71

0.025 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 10

    Oct

  • 27

    Oct

FUN

Cedar Fair

$55.07

0.88 (1.62%)

07:28
08/22/19
08/22
07:28
08/22/19
07:28
Upgrade
Cedar Fair rating change  »

Cedar Fair upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

TIF

Tiffany

$84.51

2.27 (2.76%)

07:26
08/22/19
08/22
07:26
08/22/19
07:26
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

NVO

Novo Nordisk

$51.82

0.54 (1.05%)

07:26
08/22/19
08/22
07:26
08/22/19
07:26
Hot Stocks
Novo Nordisk says EC grants extension of indication for Fiasp »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 25

    Sep

AZN

AstraZeneca

$45.42

0.8 (1.79%)

07:24
08/22/19
08/22
07:24
08/22/19
07:24
Hot Stocks
AstraZeneca agrees to buy FDA Priority Review Voucher from Sobi for $95M »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

AAPL

Apple

$212.69

2.34 (1.11%)

07:23
08/22/19
08/22
07:23
08/22/19
07:23
Periodicals
Apple plans to launch Pro iPhones with 3-sensor camera systems, Bloomberg says »

Apple is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$45.42

0.8 (1.79%)

, FGEN

FibroGen

$44.90

0.36 (0.81%)

07:23
08/22/19
08/22
07:23
08/22/19
07:23
Hot Stocks
AstraZeneca says Roxadustat approved in China for new anemia indication »

AstraZeneca (AZN)…

AZN

AstraZeneca

$45.42

0.8 (1.79%)

FGEN

FibroGen

$44.90

0.36 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 16

    Sep

  • 25

    Sep

  • 02

    Oct

DK

Delek US

$33.35

0.555 (1.69%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Downgrade
Delek US rating change  »

Delek US downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$30.14

4.165 (16.04%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$30.81

0.315 (1.03%)

, MSFT

Microsoft

$138.77

1.52 (1.11%)

07:22
08/22/19
08/22
07:22
08/22/19
07:22
Initiation
Slack Technologies, Microsoft initiated  »

Slack Technologies…

WORK

Slack Technologies

$30.81

0.315 (1.03%)

MSFT

Microsoft

$138.77

1.52 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

MSGN

MSG Networks

$14.78

-2.07 (-12.28%)

07:21
08/22/19
08/22
07:21
08/22/19
07:21
Recommendations
MSG Networks analyst commentary  »

MSG Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$103.11

17.54 (20.50%)

07:19
08/22/19
08/22
07:19
08/22/19
07:19
Recommendations
Target analyst commentary  »

Target price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

MSG

Madison Square Garden

$260.99

-6.38 (-2.39%)

07:19
08/22/19
08/22
07:19
08/22/19
07:19
Initiation
Madison Square Garden initiated  »

Madison Square Garden…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$108.00

9.96 (10.16%)

07:16
08/22/19
08/22
07:16
08/22/19
07:16
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.